A critical evaluation of the evidence for ovarian conservation versus removal at the time of hysterectomy for benign disease

Journal of Women's Health

Volumn 22, Issue 9, 2013, Pages 755-759

  Matthews, Catherine A ^a  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; TESTOSTERONE;

ARTICLE; BILATERAL SALPINGOOOPHORECTOMY; CANCER HORMONE THERAPY; CANCER PATIENT; CLINICAL TRIAL (TOPIC); COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; DISEASE ASSOCIATION; DYSPAREUNIA; ESTROGEN BLOOD LEVEL; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; HYSTERECTOMY; ISCHEMIC HEART DISEASE; LIBIDO DISORDER; MENOPAUSAL SYNDROME; ORGAN PRESERVATION; OSTEOPOROTIC HIP FRACTURE; OVARIAN CONSERVATION; OVARIECTOMY; OVARY; OVARY CANCER; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SALPINGOOOPHORECTOMY; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SURGICAL MORTALITY; SURGICAL RISK; TESTOSTERONE BLOOD LEVEL; VAGINAL DRYNESS;

ADNEXAL DISEASES; AGE FACTORS; CARDIOVASCULAR DISEASES; FEMALE; HIP FRACTURES; HUMANS; HYSTERECTOMY; OVARIAN NEOPLASMS; OVARIECTOMY; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE;

EID: 84883731773     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2013.4259     Document Type: Article

References (52)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249
2. Asante A, Whiteman MK, Kulkarni A, Cox S, Marchbanks PA, Jamieson DJ. Elective oophorectomy in the United States: Trends and in-hospital complications, 1998-2006. Obstet Gynecol 2010;116:1088-1095
3. American Congress of Obstetricians and Gynecologists. ACOG practice bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy. Obstet Gynecol 2008;111:231-241
4. Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 2005;106:219-226
5. Jacoby VL, Vittinghoff E, Nakagawa S, et al. Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions. Obstet Gynecol 2009;113:1259-1267
6. Wu JM, Wechter ME, Geller EJ, Nguyen TV, Visco AG. Hysterectomy rates in the United States, 2003. Obstet Gynecol 2007;110:1091-1095
7. Whiteman MK, Hillis SD, Jamieson DJ, et al. Inpatient hysterectomy surveillance in the United States, 2000-004. Am J Obstet Gynecol 2008;198:34 e31-37
8. American Cancer Society (ACS). Cancer facts and figures 2012. Atlanta: American Cancer Society, 2012. www.can cer.org/acs/groups/content/ @epidemiologysurveilance/ documents/document/acspc-031941.pdf Accessed December 1, 2012
9. Rebbeck TR, Kauff ND, Domchek SM. Meta-Analysis of risk reduction estimates associated with risk-reducing salpingooophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 2009;101:80-87
10. Boyd J. Molecular genetics of hereditary ovarian cancer. Oncology (Williston Park) 1998;12:399-406; discussion 409-310, 413
11. Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-1130
12. Kauff ND, Satagopan JM, Robson ME, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002;346:1609-1615
13. Hogg R, Friedlander M. Biology of epithelial ovarian cancer: Implications for screening women at high genetic risk. J Clin Oncol 2004;22:1315-1327
14. Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y. Lessons from BRCA: The tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res 2007;5: 35-44
15. Carlson JW, Miron A, Jarboe EA, et al. Serous tubal intraepithelial carcinoma: Its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol 2008;26:4160-4165
16. Jarboe E, Folkins A, Nucci MR, et al. Serous carcinogenesis in the fallopian tube: A descriptive classification. Int J Gynecol Pathol 2008;27:1-9
17. Kindelberger DW, Lee Y, Miron A, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol 2007; 31:161-169
18. Lee Y, Miron A, Drapkin R, et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 2007;211:26-35
19. Franceschi S, La Vecchia C, Booth M, et al. Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause. Int J Cancer. 1991;49: 57-60
20. Przybycin CG, Kurman RJ, Ronnett BM, Shih Ie M, Vang R. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 2010;34:1407-1416
21. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105-1110
22. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978;89:157-161
23. Luoto R, Kaprio J, Reunanen A, Rutanen EM. Cardiovascular morbidity in relation to ovarian function after hysterectomy. Obstet Gynecol 1995;85:515-522
24. Palmer JR, Rosenberg L, Shapiro S. Reproductive factors and risk of myocardial infarction. Am J Epidemiol 1992;136:408-416
25. Jacoby VL, Grady D, Wactawski-Wende J, et al. Oophorectomy vs. ovarian conservation with hysterectomy: Cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. Arch Intern Med 2011;171:760-768
26. de Kleijn MJ, van der Schouw YT, Verbeek AL, Peeters PH, Banga JD, van der Graaf Y. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol 2002;155:339-345
27. Hu FB, Grodstein F, Hennekens CH, et al. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 1999;159:1061-1066
28. Jacobsen BK, Nilssen S, Heuch I, Kvale G. Does age at natural menopause affect mortality from ischemic heart disease? J Clin Epidemiol 1997;50:475-479
29. van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet 1996;347:714-718
30. Parker WH, Broder MS, Chang E, et al. Ovarian conservation at the time of hysterectomy and long-Term health outcomes in the nurses' health study. Obstet Gynecol 2009;113: 1027-1037
31. Parker WH, Feskanich D, Broder MS, et al. Long-Term mortality associated with oophorectomy compared with ovarian conservation in the Nurses' Health Study. Obstet Gynecol 2013;121:709-716
32. Jacoby VL, Grady D, Sawaya GF. Oophorectomy as a risk factor for coronary heart disease. Am J Obstet Gynecol 2009; 200:140.e1-9
33. Howard BV, Kuller L, Langer R, et al. Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: The Women's Health Initiative Observational Study. Circulation 2005;111:1462-1470
34. Svanberg L. Effects of estrogen deficiency in women castrated when young. Acta Obstet Gynecol Scand Suppl 1981;106:11-15
35. Ritterband AB, Jaffe IA, Densen PM, Magagna JF, Reed E. Gonadal Function and the Development of Coronary Heart Disease. Circulation 1963;27:237-251
36. Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 2006;13:46-56
37. Madalinska JB, Hollenstein J, Bleiker E, et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 2005;23:6890-6898
38. Madalinska JB, van Beurden M, Bleiker EM, et al. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol 2006;24:3576-3582
39. Teplin V, Vittinghoff E, Lin F, Learman LA, Richter HE, Kuppermann M. Oophorectomy in premenopausal women: Health-related quality of life and sexual functioning. Obstet Gynecol 2007;109:347-354
40. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-688
41. Judd HL, Judd GE, Lucas WE, Yen SS. Endocrine function of the postmenopausal ovary: Concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab 1974;39:1020-1024
42. Judd HL, Lucas WE, Yen SS. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol 1974;118:793-798
43. Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005;294:91-96
44. Kauff ND. Is It time to stratify for BRCA mutation status in therapeutic trials in ovarian cancer? J Clin Oncol 2008;26: 9-10
45. Adashi EY, Resnick CE, Hurwitz A, Ricciarelli E, Hernandez ER, Rosenfeld RG. Ovarian granulosa cell-derived insulinlike growth factor binding proteins: Modulatory role of follicle-stimulating hormone. Endocrinology 1991;128:754-760
46. Shifren JL, Davis SR, Moreau M, et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: Results from the INTIMATE NM1 Study. Menopause 2006;13:770-779
47. Erekson EA, Martin DK, Zhu K, et al. Sexual function in older women after oophorectomy. Obstet Gynecol 2012;120: 833-842
48. Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007; 69:1074-1083
49. Cui Y, Galvin JM, Parker W, et al. Implementation of remote 3-dimensional image guided radiation therapy quality assurance for radiation therapy oncology group clinical trials. Int J Radiat Oncol Biol Phys 2013;85:271-277
50. Melton LJ, 3rd, Crowson CS, Malkasian GD, O'Fallon WM. Fracture risk following bilateral oophorectomy. J Clin Epidemiol 1996;49:1111-1115
51. Melton LJ, 3rd, Khosla S, Malkasian GD, Achenbach SJ, Oberg AL, Riggs BL. Fracture risk after bilateral oophorectomy in elderly women. J Bone Miner Res 2003;18:900-905
52. Antoniucci DM, Sellmeyer DE, Cauley JA, et al. Postmenopausal bilateral oophorectomy is not associated with increased fracture risk in older women. J Bone Miner Res 2005;20:741-747